Experienced in Hyperaldosteronism

Thilo Burkard

Basel, BS, CH 
Clinical Trials:Currently Recruiting for 2 Trials
Experienced in Hyperaldosteronism
Basel, BS, CH 
OverviewLocationsClinical Research

Overview

Thilo Burkard practices in Basel, Switzerland. Mr. Burkard is rated as an Experienced expert by MediFind in the treatment of Hyperaldosteronism. His top areas of expertise are Hypertension, Familial Hypertension, Hypertensive Heart Disease, Familial Hypercholesterolemia, and Bone Marrow Transplant.

His clinical research consists of co-authoring 79 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Hyperaldosteronism.

Gender
Male

Locations

Basel, BS, Switzerland
Other Locations
Zurich, ZH, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Swiss Postpartum Hypertension Cohort (Swiss-PPHT)
Swiss Postpartum Hypertension Cohort (Swiss-PPHT)
Enrollment Status: Recruiting
Publish Date: May 28, 2025
Intervention Type: Other
Collabree: A Targeted Behavioral Economics-based Intervention to Improve Medication Adherence in Patients With Hypertension
Collabree: A Targeted Behavioral Economics-based Intervention to Improve Medication Adherence in Patients With Hypertension
Enrollment Status: Recruiting
Publish Date: February 09, 2024
Intervention Type: Behavioral
Study Phase: Not Applicable
Identifying Most Effective Treatment Strategies to Control Arterial Hypertension in Sub-Saharan Africa - A Randomized Controlled Trial
Identifying Most Effective Treatment Strategies to Control Arterial Hypertension in Sub-Saharan Africa - A Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: October 20, 2022
Intervention Type: Other
Study Phase: Not Applicable
Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues - a Randomized, Double-blind, Placebo-controlled Trial
Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues - a Randomized, Double-blind, Placebo-controlled Trial
Enrollment Status: Completed
Publish Date: September 13, 2022
Intervention Type: Drug
Study Phase: Phase 2
Renin-angiotensin-system (RAS) Peptide Profiles in Patients With Treatment-resistant Arterial Hypertension (TRHT-01 Study). An Observational Single Centre Study
Renin-angiotensin-system (RAS) Peptide Profiles in Patients With Treatment-resistant Arterial Hypertension (TRHT-01 Study). An Observational Single Centre Study
Enrollment Status: Completed
Publish Date: February 28, 2018
View 3 Less Clinical Trials

79 Total Publications

Cohort profile: the open, prospective Community-Based chronic Care Lesotho (ComBaCaL) cohort - design, baseline chronic disease risk factors and hypertension and diabetes care cascades.
Cohort profile: the open, prospective Community-Based chronic Care Lesotho (ComBaCaL) cohort - design, baseline chronic disease risk factors and hypertension and diabetes care cascades.
Journal: BMJ open
Published: July 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Burkard's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile